# Disc Medicine, Inc.: filings

IRON · Nasdaq · CIK 1816736 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iron.md) · [Financials](/companies/iron/financials.md) · [Filings](/companies/iron/filings.md) · [Insiders](/companies/iron/insiders.md)

## Reports and events: 157 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 229, 144 166, 8-K 94, 3 47, 10-Q 18, SC 13G 17, SC 13D/A 16, SC 13G/A 16, 424B3 15, 424B5 14, CORRESP 13, UPLOAD 11, 425 10, EFFECT 10, S-4/A 9, SCHEDULE 13G/A 9, S-8 7, 10-K 6, SC 13D 6, SCHEDULE 13D/A 6, DEF 14A 5, DEFA14A 5, ARS 4, POS AM 4, 144/A 3, 3/A 3, 4/A 3, S-3 3, SCHEDULE 13G 3, 8-K/A 2, CERT 2, S-1 2, S-1/A 2, S-4 2, SEC STAFF LETTER 2, 25-NSE 1, 424B4 1, 8-A12B 1, 8-A12B/A 1, DRS 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:52 ET | [SCHEDULE 13D/A](/filings/0001193125-26-432228.md) | Ownership report, active investor, amended | 0001193125-26-432228 |
| 2026-10-22 | 17:11 ET | [8-K](/filings/0001193125-26-429105.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429105 |
| 2026-10-19 | 07:08 ET | [8-K](/filings/0001193125-26-424649.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-424649 |
| 2026-09-10 | 08:48 ET | [8-K](/filings/0001193125-26-387351.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-387351 |
| 2026-07-30 | 08:34 ET | [10-Q](/filings/0001193125-26-325034.md) | Quarterly report, period 2026-06-30 | 0001193125-26-325034 |
| 2026-07-30 | 08:32 ET | [8-K](/filings/0001193125-26-325031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-325031 |
| 2026-06-30 | 16:16 ET | [8-K](/filings/0001193125-26-290542.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-290542 |
| 2026-06-24 | 16:22 ET | [8-K](/filings/0001193125-26-281096.md) | 5.07 Shareholder vote results | 0001193125-26-281096 |
| 2026-05-05 | 08:33 ET | [10-Q](/filings/0001193125-26-205192.md) | Quarterly report, period 2026-03-31 | 0001193125-26-205192 |
| 2026-05-05 | 08:32 ET | [8-K](/filings/0001193125-26-205187.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205187 |
| 2026-04-28 | 17:02 ET | [DEF 14A](/filings/0001193125-26-187646.md) | Proxy statement, period 2026-06-18 | 0001193125-26-187646 |
| 2026-02-27 | 16:31 ET | [8-K](/filings/0001193125-26-082855.md) | 2.05 Exit or disposal costs | 0001193125-26-082855 |
| 2026-02-26 | 08:36 ET | [10-K](/filings/0001193125-26-073602.md) | Annual report, period 2025-12-31 | 0001193125-26-073602 |
| 2026-02-26 | 08:32 ET | [8-K](/filings/0001193125-26-073594.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073594 |
| 2026-02-17 | 07:42 ET | [8-K](/filings/0001193125-26-053066.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-053066 |
| 2026-02-13 | 16:28 ET | [8-K](/filings/0001193125-26-051504.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-051504 |
| 2026-01-12 | 08:37 ET | [8-K](/filings/0001193125-26-009871.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009871 |
| 2025-12-17 | 20:07 ET | [SCHEDULE 13D/A](/filings/0001628098-25-000010.md) | Ownership report, active investor, amended | 0001628098-25-000010 |
| 2025-12-08 | 08:40 ET | [8-K](/filings/0001193125-25-310664.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310664 |
| 2025-11-06 | 08:34 ET | [10-Q](/filings/0001193125-25-268200.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268200 |
| 2025-11-06 | 08:33 ET | [8-K](/filings/0001193125-25-268196.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268196 |
| 2025-10-22 | 21:44 ET | [SCHEDULE 13D/A](/filings/0001193125-25-247406.md) | Ownership report, active investor, amended | 0001193125-25-247406 |
| 2025-10-22 | 09:11 ET | [8-K](/filings/0001193125-25-245871.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-245871 |
| 2025-10-20 | 06:38 ET | [8-K](/filings/0001193125-25-242959.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242959 |
| 2025-10-17 | 08:43 ET | [8-K](/filings/0001193125-25-242026.md) | 8.01 Other events | 0001193125-25-242026 |
| 2025-10-06 | 16:20 ET | [8-K](/filings/0001193125-25-231911.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-231911 |
| 2025-08-15 | 19:16 ET | [SCHEDULE 13D/A](/filings/0001415889-25-022121.md) | Ownership report, active investor, amended | 0001415889-25-022121 |
| 2025-08-07 | 08:40 ET | [10-Q](/filings/0001816736-25-000007.md) | Quarterly report, period 2025-06-30 | 0001816736-25-000007 |
| 2025-08-07 | 08:37 ET | [8-K](/filings/0001816736-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001816736-25-000006 |
| 2025-07-14 | 08:37 ET | [8-K](/filings/0000950170-25-095466.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-095466 |
| 2025-06-13 | 17:05 ET | [8-K](/filings/0000950170-25-086352.md) | 5.07 Shareholder vote results | 0000950170-25-086352 |
| 2025-05-07 | 08:37 ET | [10-Q](/filings/0000950170-25-065069.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065069 |
| 2025-05-07 | 08:05 ET | [8-K](/filings/0000950170-25-065031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065031 |
| 2025-04-24 | 16:44 ET | [DEF 14A](/filings/0000950170-25-058142.md) | Proxy statement, period 2025-06-11 | 0000950170-25-058142 |
| 2025-03-12 | 19:57 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000305.md) | Ownership report, active investor, amended | 0000947871-25-000305 |
| 2025-03-03 | 16:01 ET | [SCHEDULE 13D/A](/filings/0000950170-25-030811.md) | Ownership report, active investor, amended | 0000950170-25-030811 |
| 2025-02-27 | 08:17 ET | [10-K](/filings/0000950170-25-028390.md) | Annual report, period 2024-12-31 | 0000950170-25-028390 |
| 2025-02-27 | 08:11 ET | [8-K](/filings/0001193125-25-037650.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-037650 |
| 2025-01-24 | 16:09 ET | [8-K](/filings/0001193125-25-012211.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-012211 |
| 2025-01-21 | 07:52 ET | [8-K](/filings/0001193125-25-009095.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-009095 |
| 2025-01-10 | 09:04 ET | [8-K](/filings/0000950170-25-003859.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-003859 |
| 2024-12-09 | 08:48 ET | [8-K](/filings/0000950170-24-134349.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134349 |
| 2024-11-15 | 16:31 ET | [8-K](/filings/0001193125-24-259855.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-259855 |
| 2024-11-12 | 08:26 ET | [10-Q](/filings/0000950170-24-124650.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124650 |
| 2024-11-12 | 08:14 ET | [8-K](/filings/0001193125-24-255200.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-255200 |
| 2024-11-08 | 08:49 ET | [8-K](/filings/0000950170-24-123718.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123718 |
| 2024-11-04 | 07:55 ET | [8-K](/filings/0000950170-24-120292.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-120292 |
| 2024-10-25 | 13:11 ET | [8-K](/filings/0000950170-24-117318.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-117318 |
| 2024-08-08 | 08:15 ET | [10-Q](/filings/0000950170-24-093357.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093357 |
| 2024-08-08 | 08:06 ET | [8-K](/filings/0001193125-24-196507.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-196507 |

Page 1 of 4. [Older](/companies/iron/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:53 ET. No prices; not investment advice.